Mixed dementia - The most common cause of dementia

Annals of the New York Academy of Sciences

Volumn 977, Issue , 2002, Pages 129-134

  Korczyn, Amos D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alzheimer's disease; Autoimmune mechanisms; Diagnosis; Mixed dementia; Pathogenesis; Vascular dementia

Indexed keywords

HYALIN;

ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; DEMENTIA; DISEASE PREDISPOSITION; GENETIC ANALYSIS; HEART DISEASE; HISTOPATHOLOGY; HUMAN; MIXED DEMENTIA; MULTIINFARCT DEMENTIA; PATHOGENESIS; PATHOPHYSIOLOGY; RISK FACTOR; STROKE;

EID: 0036452236     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04807.x     Document Type: Conference Paper

References (19)

1. Roman, G.C., T.K. Tatemichi, T. Erkinjunnti et al. 1993. Vascular dementia: Diagnostic criteria for research studies-A report of the NINDS-AIREN International Workshop. Neurology 43: 250-260.
2. McKhann, G., D.A. Drachman, M. Folstein et al. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group. Neurology 34: 939-944.
3. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, D.C.
4. Chui, H.C., J.I. Victoroff, D. Margolin et al. 1992. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease diagnostic and treatment centers. Neurology 42: 473-480.
5. Rockwood, K., I. Parhad, V.C. Hachinski et al. 1994. Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research consensus statement. Can. J. Neurol. Sci. 21: 358-364.
6. Nussbaum, M., T.A. Treves & A.D. Korczyn. 1992. DSM-III-R criteria for primary degenerative dementia and multi-infarct dementia. Alzheimer Dis. Assoc. Disord. 6: 111-118.
7. Hachinski, V.C., P. Potter & H. Merskey. 1987. Leucoaraiosis. Arch. Neurol. 44: 21-23.
8. Esiri, M.M., Z. Nagy, M.Z. Smith et al. 1999. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354: 919-920.
9. Korczyn, A.D. 1999. Vascular dementia. In Vascular Dementia. Monduzzi Editore. Bologna.
10. Mirra, S.S., A. Heyman, D. McKeel et al. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
11. Whitehouse, P. 1987. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease. Adv. Neurol. 45: 393-397.
12. Wallin, A., K. Blennow & C.G. Gottfries. 1989. Neurochemical abnormalities in vascular dementia. Dementia 1: 120-130.
13. Tsukasa, S., I. Alufuzoff, B. Winblad & A. Nordberg. 1990. Substance P-like immunoreactivity, choline acetyltransferase activity, and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Res. 521: 329-332.
14. Tohgi, H., T. Abe, M. Kimura et al. 1996. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer type dementia. J. Neurol. Transm. 103: 1211-1220.
15. Mega, M. 2000. The cholinergic deficit in Alzheimer's disease: Impact on cognition, behavior, and function. Int. J. Neuropharmacol. 3: 3-12.
16. Brun, A. & E. Englund. 1986. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann. Neurol. 19: 253-262.
17. Rezek, D.L., J.C. Morris, K.H. Fulling et al. 1987. Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging. Neurology 37: 1365-1368.
18. De la Torre, J.C. 2002. Alzheimer disease as a vascular disorder: Nosological evidence. Stroke 33: 1152-1162.
19. Nussbaum, M., T.A. Treves & A.D. Korczyn. 1992. Evaluation of the Hachinski ischemic scale in a prospective study. Dementia 3: 10-14.